LEVPROT BIOSCIENCE SL
Company details
- Active NIF/CIF: B01838846
-
-
-
-
Address: POLIG INDUSTRIAL LA CHARLUCA, CALLE C - PARCELA M (CALATAYUD)
-
-
Featured products:
More information on LEVPROT BIOSCIENCE SL
-
18/10/2024 | BORME act no.: 446774 | Register: ZARAGOZACambio de objeto social
-
04/10/2021 | BORME act no.: 440179 | Register: ZARAGOZARevocaciones
-
04/10/2021 | BORME act no.: 440180 | Register: ZARAGOZANombramientos
-
14/07/2021 | BORME act no.: 340039 | Register: ZARAGOZAAmpliación de capital
-
14/07/2021 | BORME act no.: 340039 | Register: ZARAGOZACambio de domicilio social
-
28/12/2020 | BORME act no.: 463292 | Register: ZARAGOZANombramientos
-
01/09/2020 | BORME act no.: 291837 | Register: ZARAGOZAConstitución
Other information
The CIF assigned to LEVPROT BIOSCIENCE SL is B01838846, and its commercial status is active. The company is engaged in economic activities classified under the CNAE 7211 - Investigación y desarrollo experimental en biotecnología. Additionally, it is categorized with the SIC code -.
LEVPROT BIOSCIENCE SL employs approximately Between 1 and 9 employees and records an annual turnover of less than 2 million euros. The company is registered in the Commercial Registry of Zaragoza, and has 2 registration charges. The most recent announcement in Borme was published on 18/10/2024, while the last deposit of ordinary annual accounts corresponds to the year 2023.
To find out the contact information of LEVPROT BIOSCIENCE SL, such as the telephone number, postal address, or website, you can access the Company Data module.
If you wish to obtain additional information about LEVPROT BIOSCIENCE SL, we invite you to consult any of the available financial reports, the Annual Accounts of the company, or review the incidents of defaults registered in the RAI delinquency file.
The financial, commercial, and legal information about LEVPROT BIOSCIENCE SL comes from official data sources and is automatically updated every day.
Do you want to know more about LEVPROT BIOSCIENCE SL??
Find out more about this company by consulting these reports: